[CIS PIDD] [cis-pidd] Abatacept usage in LRBA

[CIS-PIDD]

Dear Luis,
no adverse effects seen in one girl with 3-weekly IVIG (high-dose needed, 0.8g/kg) and 4-weekly abatacept (10-20mg/kg). We try to avoid giving the two infusions within the same calendar week.
best, Markus


Markus G. Seidel, M.D.
Professor of Translational Pediatric Hematology and Immunology | Div. of Pediatric Hematology-Oncology | Dept. of Pediatric and Adolescent Medicine | Medical University Graz | Auenbruggerpl. 34/2 | A-8036 Graz | Austria | T. 0043 316 385 80215| F. 0043 316 385 13717 | Secr. 0043 316 385 13485 |
Head of the Research Unit for Pediatric Hematology and Immunology |  Coordinator of the Working Group for Pediatric Immunology of the Austrian Society of Pediatrics and Adolescent Medicine

________________________________
Attention:
This e-mail and any attachment is for authorised use by the intended recipient(s) only. It may contain proprietary, confidential and/or privileged information and should not be copied, disclosed, distributed, retained or used by any other party. If you are not an intended recipient please notify the sender immediately and delete this e-mail (including attachments and copies).

Am 15.03.2016 um 21:11 schrieb CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>>:

Dear colleagues,

We have recently diagnosed two LRBA patients with ongoing autoimmunity and lung disease, under IVIG and SQ each. My question is if you have experienced infusion adverse effects while subsequent IVIG+abatacept infusion. In your experience, is there any reason to use one specific route for abatacept in LRBA?
Thanks in advance for your inputs,


Luis I. Gonzalez-Granado. MD.
Immunodeficiencies Unit.
Hospital 12 de octubre.
Research Institute Hospital 12 octubre (i+12)
Av. Cordoba S/N. 28041. Madrid. Spain
Tel. 0034606732959 /  0034913908569  /  Fax 0034913908772<tel:0034934893039>


Este correo electrónico se ha enviado desde un equipo libre de virus y protegido por Avast.
www.avast.com<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail>
<x-msg://16/#DDB4FAA8-2DD7-40BB-A1B8-4E2AA1F9FDF2>

---

You are currently subscribed to cis-pidd as: markus.seidel at medunigraz.at<mailto:markus.seidel at medunigraz.at>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396792.78d82ba41fe333edaa9195bab4e19c0e&n=T&l=cis-pidd&o=3528117

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3528117-96396792.78d82ba41fe333edaa9195bab4e19c0e at lyris.dundee.net<mailto:leave-3528117-96396792.78d82ba41fe333edaa9195bab4e19c0e at lyris.dundee.net>


---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3530978
or send a blank email to leave-3530978-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160317/6f1d9012/attachment-0001.html>